Lindbrook Capital, LLC Ligand Pharmaceuticals Inc Transaction History
Lindbrook Capital, LLC
- $1.06 Billion
- Q1 2025
A detailed history of Lindbrook Capital, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Lindbrook Capital, LLC holds 69 shares of LGND stock, worth $12,638. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69
Previous 63
9.52%
Holding current value
$12,638
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding LGND
# of Institutions
290Shares Held
19.5MCall Options Held
9KPut Options Held
0-
Black Rock Inc. New York, NY2.87MShares$526 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$383 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$194 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3927KShares$170 Million0.13% of portfolio
-
State Street Corp Boston, MA750KShares$137 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $3.09B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...